.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Dementia screening remains a critical challenge as global rates continue to rise. Recent research suggests that the choice of tool—specifically the Montreal Cognitive Assessment (MoCA) or the Alzheimer's Disease Assessment Scale-Cog-13 (ADAS-Cog-13)—may depend on a patient's unique history. Understanding cognitive screening in dementia is essential for clinicians who want to catch early decline before a formal diagnosis occurs.
The study analyzed high-risk veterans from the ADNI-DOD database. Researchers looked for links between these screeners and various biological or psychological markers. Interestingly, the results showed that the MoCA and ADAS-Cog-13 do not capture the same risk factors equally. Consequently, selecting the appropriate tool requires an understanding of the patient's background.
MoCA scores showed strong correlations with biological biomarkers and clinical depression. This makes the MoCA particularly useful for patients with a high medical risk or mood-related symptoms. Conversely, ADAS-Cog-13 scores were primarily associated with post-traumatic stress disorder (PTSD) diagnoses. This distinction suggests that clinicians should consider the patient's psychological background when selecting a screening instrument.
Therefore, a \"one-size-fits-all\" approach may be insufficient for early detection. By matching the screening tool to the patient's brief medical and psychological history, practitioners can improve diagnostic precision. This tailored approach allows for more personalized care pathways in the early stages of Alzheimer's disease.
The MoCA is more closely associated with biological biomarkers, making it a preferred choice when medical risk factors or depression are present in the clinical history.
Research indicates that ADAS-Cog-13 scores are specifically sensitive to PTSD diagnoses. Therefore, it may be the more informative tool for veteran populations or those with significant trauma histories.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Rice M et al. Differential associations of cognitive screeners with biological, psychological, and cognitive factors in high-risk older adults. J Alzheimers Dis. 2026 Mar 10. doi: 10.1177/13872877261424407. PMID: 41804748.
Nasreddine ZS et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
Mohs RC et al. The Alzheimer's Disease Assessment Scale. Int Psychogeriatr. 1996;8(2):193-203.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research in J Alzheimers Dis reveals MoCA and ADAS-Cog-13 have distinct associations with biomarkers and PTSD, aiding tailored dementia screening....
7 months ago
An observational study from the NIH All of Us Research Program reveals that adding a multi-ancestry polygenic risk score to machine learning models provides only modest improvements in predicting adult weight gain, underscoring the enduring significance of routine clinical and lifestyle factors.
Today
A study in JAMIA Open shows lightweight open-source reasoning LLMs achieve up to 95% sensitivity and accelerate evidence synthesis screening by nearly twentyfold, presenting a cost-effective, scalable AI solution for biomedical research and systematic reviews.
Today
A landmark study details how an enterprise pediatric remote patient management model expanded from a single cardiology pilot to 16 diverse specialty programs by combining centralized digital operations with specialty clinical leadership.
Yesterday
A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Yesterday
A breakthrough ultrathin multimodal sensor decouples physical hemodynamic monitoring from disposable electrochemical calibration, achieving long-term wearable glucose prediction with 81.36% accuracy and a 9.12% MARD. This offers a robust, drift-free solution for outpatient metabolic surveillance.
Yesterday
